Myriad Genetics (MYGN) Lung Cancer Test Successful Predicts Death in Early … – StreetInsider.com (subscription)

by lowes1 on September 25, 2013

Myriad Genetics (MYGN) Lung Cancer Test Successful Predicts Death in Early
StreetInsider.com (subscription)
Myriad Genetics, Inc. (Nasdaq: MYGN) announced new data published in Clinical Cancer Research that showed the myPlan Lung Cancer test is a significant predictor of lung cancer death in patients with early-stage, resectable lung adenocarcinoma and 

and more »

View full post on lung cancer – Google News

Leave a Comment

Previous post:

Next post: